Showing results (3441-3450 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|September 8, 2018
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell CarcinomaToni K Choueiri, M Dror Michaelson, Edwin M Posadas, et al.
The Oncologist|August 22, 2018
A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01)Keun-Wook Lee, Chi Hoon Maeng, Tae-You Kim, et al.
The Oncologist|August 15, 2018
Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT StudyKonstantinos Syrigos, Dimitra Grapsa, Rabiatou Sangare, et al.
The Oncologist|August 19, 2018
Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast CancerCourtney P Williams, Kelly M Kenzik, Andres Azuero, et al.
The Oncologist|August 18, 2018
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid TumorsGregory L Beatty, Safi Shahda, Thaddeus Beck, et al.
The Oncologist|May 25, 1999
Rhabdomyosarcoma: an overviewR Dagher, L Helman
The Oncologist|May 25, 1999
Long-term survivors of childhood cancer: the late effects of therapyC L Schwartz
The Oncologist|January 1, 1996
We've Got a Treatment, but What's the Disease? Or A Brief History of Hypofractionation and Its Relationship to Stereotactic RadiosurgeryRosenthal, Glatstein
The Oncologist|January 1, 1996
Staging Laparotomy in the Management of Hodgkin's Disease: Is It Still Necessary?Multani, Grossbard
The Oncologist|January 1, 1996
Interleukin 12: Basic Biology and Potential Applications in Cancer TreatmentRobertson, Ritz
Pageof 571